Abstract
Purpose
Recently, functional cannabinoid receptor-1 (CB1) and vanilloid receptor-1 (TRPV1) have been described in human prostate and prostate cancer-derived cell lines where the activation of the receptors resulted in inhibition of cellular growth. We, however, lack the description of the expression of these molecules in human prostate cancer (PCC) and in benign prostate hyperplasia (BPH).
Methods
Therefore, immunohistochemistry, Western blotting, and quantitative “real-time Q-PCR were performed to define the expressions of CB1 and TRPV1 in healthy and diseased prostate tissues.
Results
CB1 was identified in epithelial and smooth muscle cells types of the human prostate, whereas TRPV1 was exclusively localized to the mucosal cells. We also found that the expression of CB1 and TRPV1 (both at the protein and mRNA levels) were significantly up-regulated in PCC. However, while the increased expression of TRPV1 showed a proper correlation with increasing PCC tumor grades, such phenomenon was not observed with CB1. In addition, we also measured markedly elevated CB1 levels in BPH tissues whilst the expression of TRPV1 was not altered when compared to healthy control prostate.
Conclusions
Our findings strongly argue for that (1) the CB1 and TRPV1 molecules as well as their ligands may indeed possess a promising future role in the treatment of PCC; (2) TRPV1 may also serve as a prognostic factor in PCC; and (3) CB1 may act as a potential target molecule in the therapeutic management of BPH.
Similar content being viewed by others
References
Bodó E, Kovács I, Telek A, Varga A, Paus R, Kovács L et al (2004) Vanilloid receptor-1 is widely expressed on various epithelial and mesenchymal cell types of human skin. J Invest Dermatol 123:410–413. doi:10.1111/j.0022-202X.2004.23209.x
Bodó E, Bíró T, Telek A, Czifra G, Griger Z, Tóth IB et al (2005) A “hot” new twist to hair biology: Involvement of vanilloid receptor-1 (VR1/TRPV1) signaling in human hair growth control. Am J Pathol 166:985–998
Casanova ML, Blazquez C, Martinez-Palacio J, Villanueva C, Fernandez-Acenero MJ, Huffman JW et al (2003) Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest 111:43–50
Caterina MJ, Julius D (2001) The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 24:487–517. doi:10.1146/annurev.neuro.24.1.487
De Petrocellis L, Cascio MG, Di Marzo V (2004) The endocannabinoid system: a general view and latest additions. Br J Pharmacol 141:765–774. doi:10.1038/sj.bjp.0705666
Di Marzo V, Bifulco M, De Petrocellis L (2004) The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 3:7712–7784. doi:10.1038/nrd1495
Fixemer T, Wissenbach U, Flockerzi V, Bonkhoff H (2003) Expression of the Ca2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression. Oncogene 22:7858–7861. doi:10.1038/sj.onc.1206895
Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P et al (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232:54–61. doi:10.1111/j.1432-1033.1995.tb20780.x
Griger Z, Páyer E, Kovács I, Tóth IB, Kovács L, Sipka S et al (2007) Protein kinase Cβ and δ isoenzymes promote arachidonic acid production and proliferation of MonoMac-6 cells. J Mol Med 85:1031–1042. doi:10.1007/s00109-007-0209-y
Lazzeri M, Vannucchi MG, Zardo C, Spinelli M, Beneforti P, Turini D et al (2004) Immunohistochemical evidence of vanilloid receptor 1 in normal human urinary bladder. Eur Urol 46:792–798. doi:10.1016/j.eururo.2004.08.007
Lazzeri M, Vannucchi MG, Spinelli M, Bizzoco E, Beneforti P, Turini D et al (2005) Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder. Eur Urol 48:691–698. doi:10.1016/j.eururo.2005.05.018
Mori A, Lehmann S, O’Kelly J, Kumagai T, Desmond JC, Pervan M et al (2006) Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Cancer Res 66:3222–3229. doi:10.1158/0008-5472.CAN-05-0087
Nithipatikom K, Endsley MP, Isbell MA, Falck JR, Iwamoto Y, Hillard CJ et al (2004) 2-Arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion. Cancer Res 64:8826–8830. doi:10.1158/0008-5472.CAN-04-3136
Pacher P, Batkai S, Kunos G (2005) Cardiovascular pharmacology of cannabinoids. Handb Exp Pharmacol 168:599–625. doi:10.1007/3-540-26573-2_20
Paus R, Schmelz M, Bíró T, Steinhoff M (2006) Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest 116:1174–1186. doi:10.1172/JCI28553
Ruiz-Llorente L, Sanchez MG, Carmena MJ, Prieto JC, Sanchez-Chapado M, Izquierdo A et al (2003) Expression of functionally active cannabinoid receptor CB1 in the human prostate gland. Prostate 54:95–102. doi:10.1002/pros.10165
Sanchez MG, Sanchez AM, Collado B, Malagarie-Cazenave S, Olea N, Carmena MJ et al (2005) Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue. Eur J Pharmacol 515:20–27. doi:10.1016/j.ejphar.2005.04.010
Sanchez AM, Sanchez MG, Malagarie-Cazenave S, Olea N, Diaz-Laviada I (2006) Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin. Apoptosis 11:89–99. doi:10.1007/s10495-005-3275-z
Sarfaraz S, Afaq F, Adhami VM, Mukhtar H (2005) Cannabinoid receptor as a novel target for the treatment of prostate cancer. Cancer Res 65:1635–1641. doi:10.1158/0008-5472.CAN-04-3410
Stein RJ, Santos S, Nagatomi J, Hayashi Y, Minnery BS, Xavier M et al (2004) Cool (TRPM8) and hot (TRPV1) receptors in the bladder and male genital tract. J Urol 712:1175–1178. doi:10.1097/01.ju.0000134880.55119.cf
Telek A, Bíró T, Bodó E, Tóth IB, Borbíró I, Kovács L et al (2007) Inhibition of human hair follicle growth by endo- and exocannabinoids. FASEB J 21:3534–3541. doi:10.1096/fj.06-7689com
Varga A, Czifra G, Tállai B, Németh T, Kovács I, Kovács L et al (2004) Tumor grade-dependent alterations in the protein kinase C isoform pattern in urinary bladder carcinomas. Eur Urol 46:462–465
Xu X, Liu Y, Huang S, Liu G, Xie C, Zhou J et al (2006) Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma. Cancer Genet Cytogenet 171:31–38. doi:10.1016/j.cancergencyto.2006.06.014
Zhang L, Barritt GJ (2006) TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function? Endocr Relat Cancer 13:27–38. doi:10.1677/erc.1.01093
Acknowledgments
This work was supported by Hungarian research grants: OTKA 63153, OTKA 49231, ETT 480/2006, ETT 482/2006, RET 06/2004. The authors state no competing financial interest. T.B. is a recipient of the János Bolyai research scholarship of the Hungarian Academy of Sciences.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Czifra, G., Varga, A., Nyeste, K. et al. Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in human prostate carcinoma. J Cancer Res Clin Oncol 135, 507–514 (2009). https://doi.org/10.1007/s00432-008-0482-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-008-0482-3